모바일 심장 텔레메트리 모니터 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Mobile Cardiac Telemetry Monitors Market size is expected to reach USD 5.87 Billion in 2034 from USD 2.01 Billion (2025) growing at a CAGR of 12.67% during 2026-2034.

The global mobile cardiac telemetry monitors market is growing steadily due to the increasing prevalence of cardiovascular diseases and the rising demand for remote patient monitoring solutions. Mobile cardiac telemetry monitors are wearable devices that continuously track heart rhythms and transmit data to healthcare providers in real time. These devices help detect irregular heart activity and enable early medical intervention.

One of the major drivers of this market is the growing adoption of telehealth and remote monitoring technologies. Healthcare providers are increasingly using mobile cardiac telemetry systems to monitor patients outside of hospital settings, improving patient convenience and reducing healthcare costs. Additionally, advancements in wearable medical technology are improving device accuracy and usability.

Looking ahead, the mobile cardiac telemetry monitors market is expected to expand as digital health technologies continue to evolve. Integration with cloud-based healthcare platforms and advanced data analytics will further enhance monitoring capabilities. With increasing focus on preventive healthcare and remote patient management, demand for mobile cardiac monitoring solutions is likely to grow globally.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Lead-Based
• Patch-Based

By Indication

• Angina Pectoris
• Coronary Artery Disease
• Atherosclerosis
• Heart Failure
• Stroke
• Other

By End-Use

• Hospitals
• Specialty Clinics
• Diagnostic Centers
• Homecare Settings
• Other

COMPANIES PROFILED

• Acs Diagnostics, Baxter International Inc, Biotricity Inc, Boston Scientific Cardiac Diagnostics Inc, iRhythm Technologies, Inc, Koninklijke Philips NV, Medicomp Systems, ScottCare Cardiovascular Solutions, Telerhythmics LLC, Zoll Medical Corporation, BioTelemetry, Inc, Welch Allyn, Applied Cardiac Systems Inc, Preventice Solutions, Medtronic PLC
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MOBILE CARDIAC TELEMETRY MONITORS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Lead-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Patch-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MOBILE CARDIAC TELEMETRY MONITORS MARKET: BY INDICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Indication
• 5.2. Angina Pectoris Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Coronary Artery Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Atherosclerosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Heart Failure Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Stroke Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MOBILE CARDIAC TELEMETRY MONITORS MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Homecare Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MOBILE CARDIAC TELEMETRY MONITORS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Indication
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Indication
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Indication
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Indication
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Indication
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL MOBILE CARDIAC TELEMETRY MONITORS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Acs Diagnostics
  • 9.2.2 Baxter International Inc
  • 9.2.3 Biotricity Inc
  • 9.2.4 Boston Scientific Cardiac Diagnostics Inc
  • 9.2.5 IRhythm TechnologiesInc
  • 9.2.6 Koninklijke Philips N.V
  • 9.2.7 Medicomp Systems
  • 9.2.8 ScottCare Cardiovascular Solutions
  • 9.2.9 Telerhythmics LLC
  • 9.2.10 Zoll Medical Corporation
  • 9.2.11 BioTelemetryInc
  • 9.2.12 Welch Allyn
  • 9.2.13 Applied Cardiac Systems Inc
  • 9.2.14 Preventice Solutions
  • 9.2.15 Medtronic PLC